Only Trp53−/−, and not Trp53+/+ or Trp53+/− adenoma cells, progressed to advanced LUAD30, enabling in vivo tracking of morphologically distinct stages from AT2 to preinvasive adenoma to LUAD. This evidence concerns the gene TP53 and adenoma.